Mesenchymal Stromal Cells Respond to SARS-CoV-2 Peptides and Exhibit Altered T-Cell Regulatory Capacity
Cells · 26.03.2026 · 15 (7) · 592
DOI: 10.3390/cells15070592 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 26.03.2026. Verfasst von Sabrina Summer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Experimental Medicine, Department for Biomedical Research, University for Continuing Education Krems, 3500 Krems, Austria. Hauptthemen laut MEDLINE: SARS-CoV-2, Mesenchymal Stem Cells, T-Lymphocytes, Regulatory, COVID-19. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Research Fund, European Regional Development Fund, European Regional Development Fund INTERREG.
Abstract (Originalsprache)
Background
MSCs possess strong immunoregulatory properties and play a central role in maintaining immune homeostasis by limiting inflammatory responses. Their function is highly plastic and influenced by environmental cues, including viral signals. How SARS-CoV-2-derived antigens affect MSC immunoregulation remains incompletely understood. This study aimed to investigate the impact of SARS-CoV-2 peptides on MSC-mediated immune modulation of T-cells.
Methods
MSCs were stimulated directly with SARS-CoV-2 spike protein S peptides or cocultured with SARS-CoV-2 peptide-activated T-cells. TLR4 surface expression and receptor downstream signaling were assessed to evaluate pathway activation. MSC immunoregulatory function was analyzed by measuring suppression of TNF-α and IFN-γ expression and induction of CD4+FOXP3+ regulatory T-cells. TLR4 inhibition and lipopolysaccharide (LPS) stimulation were used to examine pathway specificity and interaction.
Results
SARS-CoV-2 peptides activated TLR4-associated signaling in MSCs, increasing TLR4 expression and NF-κB phosphorylation. Peptide-treated MSCs showed impaired suppression of pro-inflammatory cytokines and reduced induction of regulatory T-cells. TLR4 inhibition prevented these effects. LPS induced similar effects, while combining LPS and peptide stimulation partially restored physiological T-cell cytokine suppression.
Conclusions
SARS-CoV-2 peptides modulate MSC immunoregulatory function on T-cells via TLR4-dependent mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Experimental Medicine, Department for Biomedical Research, University for Continuing Education Krems, 3500 Krems, Austria.
- Faculty of Medicine, Sigmund Freud Private University, 1020 Vienna, Austria.
- Center for Biomedical Technology, Department for Biomedical Research, University for Continuing Education Krems, 3500 Krems, Austria.
- Department for Blood Group Serology and Transfusion Medicine, Medical University of Vienna, 1090 Vienna, Austria.
ORCID-Profile: Viktoria Weber
Förderung
- Austrian Research Fund
- European Regional Development Fund
- European Regional Development Fund INTERREG
- Austrian Research Fund FWF
Zitieren
APA
Summer, S., Wolf, H. M., Weber, V., & Fischer, M. B. (2026). Mesenchymal Stromal Cells Respond to SARS-CoV-2 Peptides and Exhibit Altered T-Cell Regulatory Capacity. Cells, 15(7), 592. https://doi.org/10.3390/cells15070592
Vancouver
Summer S, Wolf HM, Weber V, Fischer MB. Mesenchymal Stromal Cells Respond to SARS-CoV-2 Peptides and Exhibit Altered T-Cell Regulatory Capacity. Cells. 2026;15(7):592. doi:10.3390/cells15070592
BibTeX
@article{Summer2026,
author = {Summer, Sabrina and Wolf, Hermann Maximilian and Weber, Viktoria and Fischer, Michael B},
title = {Mesenchymal Stromal Cells Respond to SARS-CoV-2 Peptides and Exhibit Altered T-Cell Regulatory Capacity},
journal = {Cells},
year = {2026},
volume = {15},
number = {7},
pages = {592},
doi = {10.3390/cells15070592}
}
EUVIMED